Trial Profile
A pilot bioequivalance study of PUR 0200 in healthy volunteers
Status:
Active, no longer recruiting
Phase of Trial:
Phase I
Latest Information Update: 03 Mar 2017
Price :
$35
*
At a glance
- Drugs Tiotropium bromide (Primary)
- Indications Chronic obstructive pulmonary disease
- Focus Adverse reactions; Pharmacokinetics
- 03 Mar 2017 New trial record